Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 858 across all filing types
Latest filing 2022-05-24 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2022-05-24 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated May 20, 2022, reporting the submission of matters to a vote of security holders at the company's 2022 Annual Meeting of Stockholders. It details the voting results for election of directors, ratification of the independent auditor, and advisory vote on executive compensation. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not a full annual report, audit report, or management report, but specifically reports voting outcomes. The length is under 5,000 characters and contains detailed vote counts, confirming it is a voting results announcement rather than a report publication or regulatory filing. Therefore, the correct classification is DVA with high confidence.
2022-05-20 English
FORM 4
Director's Dealing
2022-05-10 English
10-Q
Interim / Quarterly Report Q1 2022
2022-04-26 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key section is Item 2.02, which states that the company issued a press release announcing financial results for the quarter ended March 31, 2022. The document itself does not contain the financial results but references a press release attached as Exhibit 99.1. The document length is 3681 characters, which is relatively short and mainly serves as an announcement of the earnings release rather than the earnings release itself. According to the 'Menu vs Meal' rule, since this document is short and references an attached press release for the financial results, it should be classified as an Earnings Release (ER) if the press release text was included. However, since the actual financial results are not included here and only the announcement of the press release is made, this is a Regulatory Filing (RNS) reporting the earnings release event. Therefore, the best classification is Regulatory Filings (RNS) with high confidence.
2022-04-25 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement related to shareholder voting matters. It includes information about the upcoming Annual Meeting, voting items such as election of directors, ratification of auditors, and advisory approval of executive compensation. The document is titled 'Definitive Additional Materials' for the proxy statement and does not contain financial statements or detailed financial analysis. It is primarily focused on soliciting shareholder votes and providing information for that purpose. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it is not merely an announcement of a report; it contains substantive proxy materials. Hence, the correct classification is PSI with high confidence.
2022-04-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.